Latest Options News

AdAlta Limited has raised up to A$1.1 million through a private placement, boosting its war chest to advance innovative cellular immunotherapy projects targeting solid cancers.

Neuren Pharmaceuticals has secured FDA Fast Track designation for its drug NNZ-2591 targeting Phelan-McDermid syndrome, accelerating its path through clinical development. This milestone underscores the urgent need for treatments in rare neurodevelopmental disorders.

Radiopharm Theranostics has completed a A$35 million institutional placement and launched a A$5 million Share Purchase Plan, both at $0.03 per share, to fund drug manufacturing and clinical trials through 2027.

Prospech Limited reports steady progress on rare earth element metallurgy at its Korsnäs project and promising gold-silver drill results in Slovakia, backed by a fully subscribed $2.1 million capital raising.

Resolution Minerals secures a $2 million placement from Tribeca Investment Partners, reinforcing its position in the U.S. critical minerals sector and advancing exploration at the strategically important Horse Heaven Project.

Deep Yellow Ltd announces the departure of long-serving CEO John Borshoff, with CFO Craig Barnes stepping in as interim leader while a global search for a successor continues.

Perpetual Limited reported a robust first quarter for FY26, with growth across its Asset Management, Corporate Trust, and Wealth Management divisions, driven by strong market returns and strategic initiatives.

Rimfire Pacific Mining has announced a maiden Inferred Mineral Resource Estimate for its Currajong scandium prospect, boosting its total scandium inventory by 61% to 5,449 tonnes. The resource remains open for expansion, with further drilling planned at Murga and Rabbit Trap projects.

Litchfield Minerals has raised $6 million from top-tier institutional investors to accelerate exploration at its promising Oonagalabi copper-zinc prospect in Australia's Northern Territory.

BCAL Diagnostics has established a $10 million convertible note facility, with $5 million already committed, to accelerate its cancer detection technologies and commercial milestones.

Zip Co Limited has reported a near doubling in cash earnings for Q1 FY26, driven by robust transaction growth and improved operating leverage, particularly in the US market. The company also doubled its share buy-back program and raised its US transaction volume growth guidance.

Black Cat Syndicate reports visible antimony mineralisation in initial drill holes at Mt Clement, advancing one of Australia’s largest antimony deposits with assays due in November 2025.